Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/69293E9F.svg?ark=w1%2F20260515%2F69293E9F)](https://nobleid.org/work/w1/20260515/69293E9F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors